GH1 and pituitary gland adenoma: We performed somatic variant profiling based on whole-exome sequencing (WES) and targeted resequencing analysis in a large and well-characterized collection of 50 of 140 patients with acromegaly with pure GH-expressing pituitary adenomas without GNAS variants (Fig. 1).